Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Medios AG

Körber is an international technology group that focuses on transforming entrepreneurial thinking into customer success and shaping technological change. The company employs over 12,000 people at more than 100 locations worldwide.

Körber

biosyn Arzneimittel GmbH is involved in the pharmaceutical and biotech sectors, specializing in trace elements, particularly high-dose selenium injections, and operates unique GMP-active ingredient manufacturing plants.

biosyn Arzneimittel GmbH

Medios is involved in the specialty pharmaceuticals sector, ensuring that innovative medication therapies reach patients across Europe.

Metric
Company Name	Medios AG	Körber	biosyn Arzneimittel GmbH
Symbol	ILM1
MSH ID	AG:MEDIOS	COM:KOERBER	DE:BIOSYN
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Technology	Healthcare & Health Services
Industry	Medical - Distribution	Technology and Engineering	Pharmaceuticals
Country	DE	DE	DE
Stage
Employee Count	500
Website	medios.ag	koerber.com	biosyn.de
LinkedIn		k%C3%B6rber	biosyn-arzneimittel-gmbh
Founders

Metric
Market Cap	445.36M
Enterprise Value
Monthly Web Traffic		1.46K
Web Traffic Growth		0.82
Valuation
Raised Capital

Metric
Revenue	1.93B
Revenue (LTM)
Revenue (NTM)
Gross Profit	56.19M
EBITDA	54.03M
Operating Income	31.27M
Net Income	20.35M
EPS	0.85
Diluted EPS	0.85
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.06
Operating Profit Margin	0.02
EBITDA Margin	0.03
Net Profit Margin	0.01
Return on Equity	0.04
Return on Assets	0.03
Return on Capital Employed	0.06

AG:MEDIOS

Medios

Last Close

13.30

10/03 08:52

Market Cap

411.66M

Beta: -

Volume Today

11.02K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	19.67
P/B Ratio	0.80
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.26
EV Multiple	10.93

Metric
Days Sales Outstanding	30.02
Days Payables Outstanding	17.80
Days Inventory Outstanding	19.65
Operating Cycle	47.60
Cash Conversion Cycle	29.19
Asset Turnover	3.04

Metric
Operating Cash Flow	15.74M
Free Cash Flow	14.37M
Cash Flow to Debt	4.96
Operating Cash Flow/Sales	0.07
Free Cash Flow Yield	0.07

Metric
Cash & Equivalents	76.86M
Accounts Receivable
Inventory	65.38M
Goodwill	220.93M
Debt to Capitalization	0.32
Debt to Assets
Current Ratio	2.55
Quick Ratio	2.47

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue